Abstract:Objective To investigate the impacts of planning target volume (VPTV), maximal heart distance (MHD), central lung distance (CLD), and cardiothoracic ratio (CTR) on intensity-modulated radiotherapy (IMRT) after breast-conserving surgery for breast cancer. Methods Forty-eight patients with breast cancer (31 with left-sided breast cancer and 17 with right-sided breast cancer) who received whole-breast IMRT after breast-conserving surgery in our hospital from 2016 to 2017 were enrolled as subjects. The prescribed radiation dose for PTV was 50 Gy in 25 fractions. In IMRT planning for each patient, the Objective function was optimized using physical parameters and the equivalent uniform dose. The relationship of influencing factors with dose-volume histogram, conformal index (CI), and homogeneity index (HI) for organ at risk was predicted using univariate and multivariate linear regression analyses. Results CTR and VPTV were independent influencing factors for CI in patients with left-sided breast cancer (R2=0.56, P=0.04;R2=0.56, P=0.00). CLD was an independent influencing factor for HI in patients with left-sided breast cancer (R2=0.17, P=0.023). VPTV was an independent influencing factor for CI in patients with right-sided breast cancer (R2=0.48, P=0.00). MHD and CTR were predictors for VHeart30 of the heart. MHD and CLD were predictors for DmaxHeart of the heart. The prediction formulae for left-sided breast cancer were CI=0.38+0.32CTR and HI=1.06+0.02CLD. CI was 0.48 at the right side. At the left side, Vlung20=12.68+3.18CLD, Vlung10=18.78+4.3CLD, Vlung5=26.2+5.2CLD, and Dmeanlung=686.7+210.1CLD. For the heart, VHeart30=-13.65+30.5CTR+1.9MHD and DmaxHeart=5140.1+248.9MHD-195.6CLD. There was no correlation of patient′s heart volume with MHD, VHeart10, VHeart5, DmeanHeart, or DmaxHeart. There was no correlation of whole lung volume with CLD, Vlung20, Vlung10, Vlung5, or Dmeanlung. The mean values of CI and HI were 0.63±0.06(0.46-0.72) and 1.09±0.02(1.07-1.14) in radiotherapy plans for left-sided breast cancer, and 0.65±0.08(0.48-0.76) and 1.09±0.04(1.03-1.18) in radiotherapy plans for right-sided breast cancer, respectively. Conclusions CTR, CLD, and MHD can predict the rationality of each parameter in IMRT planning for left-sided breast cancer rather than right-sided breast cancer. The obtained formulae can help physicians choose the optimal setting mode for radiation field and improve the quality of treatment plans.
Wang Yong,Wu Bo,Ying Shenpeng et al. Impacts of patient factors on intensity-modulated radiotherapy planning after breast-conserving surgery for breast cancer[J]. Chinese Journal of Radiation Oncology, 2018, 27(5): 483-488.
[1]Vivekanandan S,Mhlanga J,Launders D,et al. Beam angle manipulation to reduce cardiac dose during breast radiotherapy[J].Br J Radiol,2012,85(1011):265-271.DOI:10.1259/bjr/58636261 [2]Baltas D,Kolotas C,Geramani K,et al. A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy[J].Int J Radiat Oncol Biol Phys,1998,40(2):515-524.DOI:10.1016/S0360-3016(97)00732-3. [3]铁剑,孙艳,弓健,等.保乳术后固定野动态调强与容积IMRT的剂量学比较[J].中华放射医学与防护杂志,2011,31(3):317-321.DOI:10.3760/cma.j.issn.0254-5098.2011.03.017. Tie J,Sun Y,Gong J,et al. Dosimetric study comparing volumetric arc modulation with RapidArc and fixed field dynamic intensity-modulated radiation therapy for breast cancer radiotherapy after breast-conserving surgery[J].Chin J Radiol Med Prot,2011,31(3):317-321.DOI:10.3760/cma.j.issn.0254-5098.2011.03.017. [4]Duma MN,Molls M,Trott KR.From heart to heart for breast cancer patients-cardiovascular toxicities in breast cancer radiotherapy[J].Strahlenther Onkol,2014,190(1):5-7.DOI:10.1007/s00066-013-0465-4. [5]de Almeida CE,Fournier-Bidoz N,Massabeau C,et al. Potential benefits of using cardiac gated images to reduce the dose to the left anterior descending coronary during radiotherapy of left breast and internal mammary nodes[J].Cancer/Radiothérapie,2012,16(1):44-51.DOI:10.1016/j.canrad.2011.07.244. [6]Shah C,Badiyan S,Berry S,et al. Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy[J].Radiother Oncol,2014,112(1):9-16.DOI:10.1016/j.radonc.2014.04.009. [7]王升晔,杜向慧,白雪,等.左侧乳腺癌改良根治术后切线野放疗中心脏最大距离预测心脏剂量探讨[J].中华放射肿瘤学杂志,2015,24(2):180-183.DOI:10.3760/cma.j.issn.1004-4221.2015.02.018. Wang SY,Du XH,Bai X,et al. Use of maximum heart distance to evaluate heart dosimetry for tangential field radiotherapy in left-sided breast cancer after modified radical mastectomy[J].Chin J Radiat Oncol,2015,24(2):180-183.DOI:10.3760/cma.j.issn.1004-4221.2015.02.018. [8]Taylor CW,Nisbet A,McGale P,et al. Cardiac exposures in breast cancer radiotherapy:1950 s-1990 s[J].Int J Radiat Oncol Biol Phys,2007,69(5):1484-1495.DOI:10.1016/j.ijrobp.2007.05.034. [9]Vees H,Bigler R,Bieri S,et al. Assessment of cardiac exposure in left-tangential breast irradiation[J].Cancer/Radiothérapie,2011,15(8):670-674.DOI:10.1016/j.canrad.2011.03.009. [10]Kimura T,Togami T,Takashima H,et al. Radiation pneumonitis in patients with lung and mediastinal tumours:a retrospective study of risk factors focused on pulmonary emphysema[J].Br J Radiol,2012,85(1010):135-141.DOI:10.1259/bjr/32629867. [11]Formenti SC,Dewyngaert JK,Jozsef G,et al. Prone vs. supine positioning for breast cancer radiotherapy[J].JAMA,2012,308(9):861-863.DOI:10.1001/2012.jama.10759. [12]Kirby AM,Evans PM,Donovan EM,et al. Prone versus supine positioning for whole and partial-breast radiotherapy:a comparison of non-target tissue dosimetry[J].Radiother Oncol,2010,96(2):178-184.DOI:10.1016/j.radonc.2010.05.014. [13]Johansen S,Tjessem KH,Fosså K,et al. Dose distribution in the heart and cardiac chambers following 4-field radiation therapy of breast cancer:a retrospective study[J].Breast Cancer,2013,7(1):41-49.DOI:10.4137/BCBCR.S11118.